Abstract: Formulations and methods for the preventative treatment of incidental opioid overdose comprising the intranasal (IN) administration of a pharmaceutical formulation containing the opioid antagonist nalmefene as a prophylactic measure.
Type:
Application
Filed:
February 8, 2024
Publication date:
June 20, 2024
Applicants:
Aegis Therapeutics, LLC, Indivior Inc.
Inventors:
Roger CRYSTAL, Phil SKOLNICK, Edward T. MAGGIO